Lv54
1062 积分 2025-06-26 加入
An Overview of Targeting Legumain for Inhibiting Cancers
16天前
已完结
A cyno cross reactive CD3 VHH antibody enables engineering of a potent CD20-targeted t cell engager with enhanced safety
1个月前
已关闭
Tumor-antigen-independent targeting of solid tumors by armored macrophage-directed anti-TREM2 CAR T cells
1个月前
已完结
A trispecific antibody engaging T cells with tumour and myeloid cells augments antitumour immunity
1个月前
已完结
Balancing brain exposure, pharmacokinetics and safety of transferrin receptor antibodies for delivery of neuro-therapeutics
3个月前
已完结
Analysis of antigen-specific T-cell responses with synthetic peptides—what kind of peptide for which purpose?
4个月前
已完结
Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
4个月前
已完结
A novel small-molecular CCR5 antagonist promotes neural repair after stroke
4个月前
已完结
Standardized protocols for differentiation of THP-1 cells to macrophages with distinct M(IFNγ+LPS), M(IL-4) and M(IL-10) phenotypes
4个月前
已完结
Dual-payload ADCs move into first oncology clinical trials
4个月前
已完结
皖公网安备34019202002308
